Ever Supreme Bio Technology Company Description

Ever Supreme Bio Technology Co., Ltd engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells.

Its products include UMC01, a drug candidate in Phase I clinical trials for the treatment of myocardial infarction and stroke; ADCV01, a drug candidate in Phase II clinical trials for the treatment of malignant brain tumor; CAR001, a chimeric antigen receptor immune cells product; and bone-marrow stem cells (BMSC), used to treat chronic stroke, degenerative osteoarthritis, and spinal cord injuries.

The company was incorporated in 2016 and is based in Taichung, Taiwan.

Ever Supreme Bio Technology Co., Ltd

Country	Taiwan
Founded	2016
Industry	Biotechnology
Sector	Healthcare

Contact Details

Address: No. 30, Keya Road Taichung Taiwan
Phone	886 4 2325 2888
Website	ever-supreme.com.tw

Stock Details

Ticker Symbol	6712
Exchange	Taipei Exchange
Fiscal Year	January - December
Reporting Currency	TWD
ISIN Number	TW0006712003
SIC Code	2836

Key Executives

Name	Position
Po-Ching Lee	Financial Manager